# Allogene Therapeutics Inc. (ALLO) — Shareholder Equity

## Annual Shareholder Equity (USD)

| Year | Shareholder Equity |
| --- | --- |
| 2025 | $293M |
| 2024 | $422M |
| 2023 | $512M |
| 2022 | $667M |
| 2021 | $925M |
| 2020 | $1.01B |
| 2019 | $629M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ALLO/shareholders-equity)